Dag Nyholm
Professor at Department of Medical Sciences; Neurology
- E-mail:
- dag.nyholm@uu.se
- Visiting address:
- Akademiska sjukhuset
- Postal address:
- Akademiska sjukhuset, ing 85 plan 2
751 85 UPPSALA
Download contact information for Dag Nyholm at Department of Medical Sciences; Neurology
- Academic merits:
- MD PhD, Associate Professor
- ORCID:
- 0000-0001-9776-7715
Short presentation
Dag Nyholm is professor of neurology and consultant physician. His research is mostly focused on movement disorders - especially optimization of treatments in Parkinson's disease, but also cervical dystonia, essential tremor, Huntington's disease, multiple system atrophy and normal pressure hydrocephalus. Projects in other areas of clinical neurology are ongoing.
Keywords
- parkinson´s disease
- neurology
- movement disorders
Biography
MD degree 1999, Uppsala University.
PhD degree 2003, Uppsala University, Pharmacotherapy for Parkinson's disease - observations and innovations
Associate professor 2009, Uppsala University.
Specialist physician, neurology, 2015, Uppsala University Hospital.
Professor of neurology, 2022, Uppsala University.
Research
Supervision of ongoing PhD projects
Optimering av djup hjärnstimulering vid motorikstörningar. Elena Jiltsova. (Main supervisor)
Development of a new biomarker for detection of prodromal Parkinson’s disease. Paul de Roos. (Main supervisor)
Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus. Madelene Braun. (Main supervisor)
Montreal Cognitive Assessment and Cognitive Effects of Interventions in Stroke. Elias Lindvall. (Co-supervisor)
Advanced Parkinson's disease: Aspects on therapies and non-motor symptoms. Sotirios Gregoriou, Lund university. (Co-supervisor)
Videobaserad analys av motorik vid normaltryckshydrocefalus och Parkinsons sjukdom. Maria Ekblom. (Co-supervisor)
Collaborations
Uppsala universitet:
Centrum för forsknings- & bioetik (CRB)
Farmaceutisk biovetenskap, Farmakometri
Folkhälso- och vårdvetenskap, Geriatrik
Folkhälso- och vårdvetenskap, Geriatrik; Molekylär geriatrik/ Rudbecklaboratoriet
Informationsteknologi, Systemteknik
Kemi - BMC, Analytisk kemi
Kirurgiska vetenskaper, Radiologi
Medicinska vetenskaper, Gastroenterologi/hepatologi
Medicinska vetenskaper, Klinisk kemi
Kvinnors och barns hälsa, Fysioterapi
Medicinska vetenskaper, Neurokirurgi
Övriga inom Sverige:
Göteborgs universitet
Högskolan i Dalarna
Karolinska institutet
Linköpings universitet
Lunds universitet
Stockholms universitet
Umeå universitet
Örebro universitet
Media
Dystonia
Dystonia Evening in Uppsala, Sweden. Dag Nyholm. film 1/3
https://www.youtube.com/watch?v=s7AQ_PT0vEw&t=2s
Digital Health
Current Current Challenges in Biomed-IT, Digital Health 1a, Dag Nyholm

Publications
Recent publications
-
Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives
Part of BMC Nursing, 2026
- DOI for Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives
- Download full text (pdf) of Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives
-
Part of Parkinsonism & Related Disorders, 2026
- DOI for Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study
- Download full text (pdf) of Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study
-
Inflammatory protein profiles and shunt response in iNPH
Part of Fluids and Barriers of the CNS, 2026
- DOI for Inflammatory protein profiles and shunt response in iNPH
- Download full text (pdf) of Inflammatory protein profiles and shunt response in iNPH
-
Characterization of a distinct form of vimentin in the neurodegenerative brain
Part of Acta neuropathologica communications, 2026
- DOI for Characterization of a distinct form of vimentin in the neurodegenerative brain
- Download full text (pdf) of Characterization of a distinct form of vimentin in the neurodegenerative brain
-
Part of Lancet Neurology, p. 550-559, 2026
All publications
Articles in journal
-
Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives
Part of BMC Nursing, 2026
- DOI for Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives
- Download full text (pdf) of Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives
-
Part of Parkinsonism & Related Disorders, 2026
- DOI for Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study
- Download full text (pdf) of Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study
-
Inflammatory protein profiles and shunt response in iNPH
Part of Fluids and Barriers of the CNS, 2026
- DOI for Inflammatory protein profiles and shunt response in iNPH
- Download full text (pdf) of Inflammatory protein profiles and shunt response in iNPH
-
Characterization of a distinct form of vimentin in the neurodegenerative brain
Part of Acta neuropathologica communications, 2026
- DOI for Characterization of a distinct form of vimentin in the neurodegenerative brain
- Download full text (pdf) of Characterization of a distinct form of vimentin in the neurodegenerative brain
-
Part of Lancet Neurology, p. 550-559, 2026
-
Part of Journal of neural transmission, p. 361-375, 2026
- DOI for COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion
- Download full text (pdf) of COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion
-
Part of NeuroImage, 2026
- DOI for A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using 11C-PE2I PET
- Download full text (pdf) of A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using 11C-PE2I PET
-
Part of Neurology and Therapy, p. 801-812, 2025
- DOI for Therapies for Advanced Parkinson's Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World Data
- Download full text (pdf) of Therapies for Advanced Parkinson's Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World Data
-
Fiber Activation in Bipolar Deep Brain Stimulation: A Patient Case Study
Part of IFAC-PapersOnLine, p. 361-366, 2025
- DOI for Fiber Activation in Bipolar Deep Brain Stimulation: A Patient Case Study
- Download full text (pdf) of Fiber Activation in Bipolar Deep Brain Stimulation: A Patient Case Study
-
Part of Movement Disorders, p. 1134-1142, 2025
- DOI for NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy
- Download full text (pdf) of NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy
-
Part of Fluids and Barriers of the CNS, 2025
- DOI for Blinded gait assessment in idiopathic normal pressure hydrocephalus: reliability and correlation with clinical and patient-reported outcomes
- Download full text (pdf) of Blinded gait assessment in idiopathic normal pressure hydrocephalus: reliability and correlation with clinical and patient-reported outcomes
-
Part of Physiotherapy Theory and Practice, p. 763-771, 2025
- DOI for “I’m still the person I am. Not the body it has become.”: An active but challenging life with cervical dystonia
- Download full text (pdf) of “I’m still the person I am. Not the body it has become.”: An active but challenging life with cervical dystonia
-
Part of European Journal of Neurology, 2025
- DOI for Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease
- Download full text (pdf) of Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease
-
Part of Journal of Neuroimaging, p. 612-618, 2024
- DOI for Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus
- Download full text (pdf) of Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus
-
Part of Palliative & Supportive Care, p. 1150-1157, 2024
- DOI for Pain in patients with motor neuron disease: Variation of pain and association with disease severity, health-related quality of life and depression – A longitudinal study
- Download full text (pdf) of Pain in patients with motor neuron disease: Variation of pain and association with disease severity, health-related quality of life and depression – A longitudinal study
-
A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease
Part of Movement Disorders Clinical Practice, p. 1609-1612, 2024
- DOI for A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease
- Download full text (pdf) of A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease
-
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
Part of Movement Disorders Clinical Practice, p. 1095-1102, 2024
- DOI for Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
- Download full text (pdf) of Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
-
Part of Physica medica (Testo stampato), 2024
- DOI for Comparison of quantitative [11C]PE2I brain PET studies between an integrated PET/MR and a stand-alone PET system
- Download full text (pdf) of Comparison of quantitative [11C]PE2I brain PET studies between an integrated PET/MR and a stand-alone PET system
-
Part of Fluids and Barriers of the CNS, 2023
- DOI for Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
- Download full text (pdf) of Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
-
Part of BMC Medical Ethics, 2023
- DOI for Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment
- Download full text (pdf) of Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment
-
Part of Acta Neurologica Scandinavica, 2023
- DOI for The Impact of COVID-19 on Parkinson's Disease: A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
- Download full text (pdf) of The Impact of COVID-19 on Parkinson's Disease: A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
-
Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy
Part of Brain, p. 1065-1074, 2023
-
Part of Fluids and Barriers of the CNS, 2022
- DOI for Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus
- Download full text (pdf) of Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus
-
Part of JMIR Formative Research, 2022
- DOI for Toward Improved Treatment and Empowerment of Individuals With Parkinson Disease: Design and Evaluation of an Internet of Things System
- Download full text (pdf) of Toward Improved Treatment and Empowerment of Individuals With Parkinson Disease: Design and Evaluation of an Internet of Things System
-
Optimizing Treatment of Parkinson's Disease
Part of Journal of Personalized Medicine, 2022
- DOI for Optimizing Treatment of Parkinson's Disease
- Download full text (pdf) of Optimizing Treatment of Parkinson's Disease
-
Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study
Part of BMC Medical Ethics, 2022
- DOI for Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study
- Download full text (pdf) of Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study
-
Part of BMC Medical Ethics, 2022
- DOI for Attitudes and values among the Swedish general public to using human embryonic stem cells for medical treatment
- Download full text (pdf) of Attitudes and values among the Swedish general public to using human embryonic stem cells for medical treatment
-
Part of Journal of Neuroimaging, p. 90-96, 2022
- DOI for Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus
- Download full text (pdf) of Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus
-
Part of Physica medica (Testo stampato), p. 36-43, 2022
- DOI for Composite attenuation correction method using a 68Ge-transmission multi-atlas for quantitative brain PET/MR.
- Download full text (pdf) of Composite attenuation correction method using a 68Ge-transmission multi-atlas for quantitative brain PET/MR.
-
Trial of Deferiprone in Parkinson’s Disease
Part of New England Journal of Medicine, p. 2045-2055, 2022
-
Part of Neurology, 2022
- DOI for Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
- Download full text (pdf) of Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
-
Close relationships in Parkinson ' s disease patients with device-aided therapy
Part of Brain and Behavior, 2021
- DOI for Close relationships in Parkinson ' s disease patients with device-aided therapy
- Download full text (pdf) of Close relationships in Parkinson ' s disease patients with device-aided therapy
-
Part of BMC Palliative Care, 2021
- DOI for Pain, disease severity and associations with individual quality of life in patients with motor neuron diseases
- Download full text (pdf) of Pain, disease severity and associations with individual quality of life in patients with motor neuron diseases
-
Part of Fluids and Barriers of the CNS, 2021
- DOI for Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism
- Download full text (pdf) of Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism
-
Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
Part of Movement Disorders, p. 481-491, 2021
- DOI for Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
- Download full text (pdf) of Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
-
Part of Journal of Personalized Medicine, 2021
- DOI for Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice
- Download full text (pdf) of Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice
-
Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice
Part of Journal of Personalized Medicine, 2021
- DOI for Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice
- Download full text (pdf) of Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice
-
An updated calculator for determining levodopa-equivalent dose
Part of Neurological Research and Practice, 2021
- DOI for An updated calculator for determining levodopa-equivalent dose
- Download full text (pdf) of An updated calculator for determining levodopa-equivalent dose
-
Part of Läkartidningen, 2020
-
A survey of lifestyle factors in dystonia.
Part of Brain and Behavior, 2020
- DOI for A survey of lifestyle factors in dystonia.
- Download full text (pdf) of A survey of lifestyle factors in dystonia.
-
Part of Movement Disorders, p. 1046-1054, 2020
-
Part of Scientific Reports, 2020
- DOI for Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism
- Download full text (pdf) of Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism
-
Part of EJNMMI Physics, 2020
- DOI for Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [11C]PE2I PET-MR brain imaging
- Download full text (pdf) of Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [11C]PE2I PET-MR brain imaging
-
Part of Occupational Therapy in Health Care, p. 1-18, 2020
-
Part of Journal of Parkinson's Disease, p. 1529-1534, 2020
-
A multiple motion sensors index for motor state quantification in Parkinson's disease
Part of Computer Methods and Programs in Biomedicine, 2020
-
Part of IEEE journal of biomedical and health informatics, p. 111-119, 2020
-
Part of Scientific Reports, 2019
- DOI for Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects
- Download full text (pdf) of Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects
-
Evaluation of a sensor algorithm for motor state rating in Parkinson's disease
Part of Parkinsonism & Related Disorders, p. 112-117, 2019
-
Part of Journal of Neurology, p. 651-658, 2019
- DOI for Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.
- Download full text (pdf) of Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.
-
The effect of continuous levodopa treatment during the afternoon hours
Part of Acta Neurologica Scandinavica, p. 70-75, 2019
-
Part of EJNMMI Physics, 2018
- DOI for Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and 68Ge-transmission-based attenuation correction
- Download full text (pdf) of Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and 68Ge-transmission-based attenuation correction
-
Part of npj Parkinson's Disease, 2018
- DOI for Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
- Download full text (pdf) of Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Part of European Journal of Clinical Pharmacology, p. 1299-1307, 2018
- DOI for Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
- Download full text (pdf) of Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
-
A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States
Part of IEEE journal of biomedical and health informatics, p. 1341-1349, 2018
-
Part of Acta Neurologica Scandinavica, p. 78-84, 2018
-
Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry
Part of CNS Neuroscience & Therapeutics, p. 439-447, 2018
-
Individual dose-response models for levodopa infusion dose optimization
Part of International Journal of Medical Informatics, p. 137-142, 2018
-
A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.
Part of Movement Disorders, p. 329-332, 2018
- DOI for A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.
- Download full text (pdf) of A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.
-
Part of Sensors, 2017
- DOI for Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings
- Download full text (pdf) of Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings
-
First clinical experience with levodopa/carbidopa microtablets in Parkinson’s disease
Part of Acta Neurologica Scandinavica, p. 727-731, 2017
-
Part of European Journal of Clinical Pharmacology, p. 563-571, 2017
-
Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study
Part of Movement Disorders, p. 283-286, 2017
-
Part of Journal of Parkinson's Disease, p. 719-728, 2017
- DOI for Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease
- Download full text (pdf) of Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease
-
Part of American Journal of Nuclear Medicine and Molecular Imaging, p. 263-274, 2017
-
Part of Artificial Intelligence in Medicine, p. 54-62, 2017
-
Part of Parkinsonism & Related Disorders, p. 17-23, 2016
- DOI for Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs
- Download full text (pdf) of Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2016
-
Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease
Part of Acta Neurologica Scandinavica, p. 208-215, 2016
-
Part of CNS Drugs, p. 1009-1010, 2016
-
Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease
Part of Sensors, p. 23727-23744, 2015
- DOI for Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease
- Download full text (pdf) of Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease
-
Part of Clinical neuropharmacology, p. 170-176, 2015
-
Use of C-11-PE2I PET in Differential Diagnosis of Parkinsonian Disorders
Part of Journal of Nuclear Medicine, p. 234-242, 2015
-
Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease
Part of IEEE journal of biomedical and health informatics, p. 1829-1834, 2015
- DOI for Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease
- Download full text (pdf) of Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease
-
Continuous drug delivery in Parkinson's disease
Part of CNS Drugs, p. 19-27, 2014
-
A computer vision framework for finger-tapping evaluation in Parkinson's disease
Part of Artificial Intelligence in Medicine, p. 27-40, 2014
-
Levodopa Fractionation in Parkinson's Disease
Part of Journal of Parkinson's Disease, p. 89-96, 2014
-
Part of AAPS Journal, p. 316-323, 2013
-
Automatic and Objective Assessment of Alternating Tapping Performance in Parkinson's Disease
Part of Sensors, p. 16965-16984, 2013
- DOI for Automatic and Objective Assessment of Alternating Tapping Performance in Parkinson's Disease
-
Computer Vision Methods for Parkinsonian Gait Analysis: A Review onPatents
Part of Recent Patents on Biomedical Engineering, p. 97-108, 2013
-
Validation of parametric methods for [(11)C]PE2I positron emission tomography
Part of NeuroImage, p. 172-178, 2013
-
Motor fluctuations and Helicobacter pylori in Parkinson's disease
Part of Journal of Neurology, p. 2974-2980, 2013
-
Spiral drawing during self-rated dyskinesia is more impaired than during self-rated off.
Part of Parkinsonism & Related Disorders, p. 553-556, 2013
-
Part of Journal of Neurology, p. 2701-2714, 2013
- DOI for Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review
- Download full text (pdf) of Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review
-
Part of Acta Neurologica Scandinavica, p. 124-132, 2013
-
Combined fine-motor tests and self-assessments for remote detection of motor fluctuations
Part of Recent Patents on Biomedical Engineering, p. 127-135, 2013
-
Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease
Part of European Journal of Neurology, p. 1079-1085, 2012
-
Part of Neurological Sciences, p. 831-838, 2012
-
Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial
Part of European Journal of Neurology, p. 820-826, 2012
-
Duodopa(®) treatment for advanced Parkinson's disease: A review of efficacy and safety
Part of Parkinsonism & Related Disorders, p. 916-929, 2012
-
Part of Clinical neuropharmacology, p. 278-282, 2012
-
Parametric methods for [11C]PE2I positron emission tomography
Part of Journal of Cerebral Blood Flow and Metabolism, 2012
-
Part of Clinical neuropharmacology, p. 111-117, 2012
-
Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease
Part of Parkinsonism & Related Disorders, p. 1000-1001, 2012
-
Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease
Part of Acta Neurologica Scandinavica, 2012
-
Part of Parkinsonism & Related Disorders, p. 686-687, 2012
-
Part of European Journal of Neurology, p. 24-24, 2012
-
Update on levodopa/carbidopa intestinal gel infusion
Part of European Neurological Review, p. 13-16, 2012
-
Part of Basal Ganglia, p. 221-226, 2012
-
Part of Annals of Neurology, p. 424-424, 2011
-
Part of European Neurological Review, p. 156-160, 2011
-
A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion
Part of Clinical neuropharmacology, p. 61-65, 2011
-
Part of Computer Methods and Programs in Biomedicine, p. 219-226, 2011
-
Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure
Part of Acta Neurologica Scandinavica, p. 237-243, 2010
-
A home environment test battery for status assessment in patients with advanced Parkinson's disease
Part of Computer Methods and Programs in Biomedicine, p. 27-35, 2010
-
Part of European Journal of Neurology, p. 260-266, 2010
-
A new computer method for assessing drawing impairment in Parkinson's disease
Part of Journal of Neuroscience Methods, p. 143-148, 2010
-
Circadian rhythmicity in levodopa pharmacokinetics in patients with Parkinson disease
Part of Clinical neuropharmacology, p. 181-185, 2010
-
Part of European Neurological Journal, p. 1-8, 2010
-
Part of Applied Health Economics and Health Policy, p. 167-180, 2009
-
Part of Acta Neurologica Scandinavica, p. 345-348, 2009
-
Part of Journal of Vascular and Interventional Radiology, p. 500-505, 2009
-
Enteral Levodopa/Carbidopa infusion in advanced Parkinson disease: Long-term exposure
Part of Clinical neuropharmacology, p. 63-73, 2008
-
Neurologi i förvandling - från diagnostik till terapeutisk disciplin
Part of Läkartidningen, p. 2413-2416, 2008
-
Irreversible motor impairment in young addicts - ephedrone, manganism or both?
Part of Acta Neurologica Scandinavica, p. 385-389, 2007
-
The rationale for continuous dopaminergic stimulation in advanced Parkinson's disease
Part of Parkinsonism & Related Disorders, 2007
-
Long-term 24-hour duodenal infusion of levodopa: Outcome and dose requirements
Part of Neurology, p. 1611-1612, 2006
-
Outcome prediction of enteral levodopa/carbidopa infusion in advanced Parkinson's disease
Part of Parkinsonism & Related Disorders, p. 509-513, 2006
-
Part of Expert Review Neurotherapeutics, p. 1403-1411, 2006
-
Pharmacokinetic optimisation in the treatment of Parkinson's disease: an update
Part of Clinical Pharmacokinetics, p. 109-136, 2006
-
Infusing levodopa to stabilise blood levels
Part of EPNN Journal, p. 10-11, 2005
-
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
Part of Neurology, p. 216-223, 2005
-
Long-term 24-hour duodenal infusion of levodopa: Outcome and dose requirements
Part of Neurology, p. 1506-1507, 2005
-
New developments in levodopa therapy
Part of Neurology, 2004
-
Part of Movement Disorders, p. 446-451, 2004
-
Levodopa infusion therapy in Parkinson Disease
Part of Clinical Neuropharmacology, p. 245-256, 2004
-
Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets
Part of Clinical neuropharmacology, p. 156-163, 2003
-
Part of International Journal of Pharmaceutics, p. 137-146, 2003
-
Part of Clinical neuropharmacology, p. 89-96, 2002
-
Part of Clin Neuropharmacol, p. 89-96, 2002
-
Duodenal levodopa infusion in Parkinson’s disease – long-term experience
Part of Acta Neurol Scand, p. 343-348, 2001
-
Articles, review/survey
-
Part of Therapeutic advances in neurological disorders, 2022
- DOI for Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance
- Download full text (pdf) of Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance
-
Effects of Helicobacter pylori on Levodopa Pharmacokinetics
Part of Journal of Parkinson's Disease, p. 61-69, 2021
- DOI for Effects of Helicobacter pylori on Levodopa Pharmacokinetics
- Download full text (pdf) of Effects of Helicobacter pylori on Levodopa Pharmacokinetics
-
Part of Upsala Journal of Medical Sciences, p. 71-77, 2017
-
Part of Therapeutic advances in neurological disorders, p. 171-187, 2017
-
Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
Part of CNS Drugs, p. 381-404, 2016
-
Complexity of Motor Response to Different Doses of Duodenal Levodopa Infusion in Parkinson Disease
Part of Clinical neuropharmacology, p. 6-14, 2012
-
Irregular gastrointestinal drug absorption in Parkinson's disease
Part of Expert Opinion on Drug Metabolism and Toxicology, p. 193-203, 2008
Books
-
Liber, 2020
-
Liber, 2012
-
Uppsala Publishing House, Uppsala, 2007
Chapters in book
-
Funktionella neurologiska sjukdomar
Part of Neurologi, Liber, 2020
-
Den neurologiska konsultationen
Part of Neurologi, Liber, 2020
-
Part of Neurologi, Liber, 2020
-
Part of Neurologi, Liber, 2020
-
Part of Signal and Image Analysis for Biomedical and Life Sciences, p. 63-82, Springer, 2015
-
Den neurologiska undersökningen
Part of Neurologi, Liber, 2012
-
Part of Neurologi, Liber, 2012
-
Part of Neurologi, Liber, 2012
-
Part of Neurologi, Liber, 2012
-
Alternatives to oral levodopa Duodopa - continuous levodopa administration
Part of Managing advanced Parkinon's disease: the role of continuous dopaminergic stimulation, Scope Medical Ltd, London, 2007
Comprehensive doctoral thesis
Conference papers
-
Neural Fiber Activation in Unipolar vs Bipolar Deep Brain Stimulation
Part of 2024 American Control Conference (ACC), p. 4530-4535, 2024
- DOI for Neural Fiber Activation in Unipolar vs Bipolar Deep Brain Stimulation
- Download full text (pdf) of Neural Fiber Activation in Unipolar vs Bipolar Deep Brain Stimulation
-
Part of ARTIFICIAL INTELLIGENCE IN MEDICINE, AIME 2019, p. 420-424, 2019
-
Part of 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), p. 131-134, 2017
-
Part of Artificial Intelligence In Medicine, p. 267-276, 2015
-
Visualization of spiral drawing data of patients with Parkinson's disease
Part of 2014 18Th International Conference On Information Visualisation (IV), p. 346-350, 2014
-
Part of International Symposium on Computational Models for Life Sciences, p. 98-107, 2013
Manuscripts (preprints)
-
Composite 68Ge attenuation correction for quantitative brain PET/MR
-
Comparison of quantitative [11C]PE2I PET scans acquired on PET/MR and stand-alone PET
-
CSF Proenkephalin decreases with the progression of Huntington's disease
-
Neural Fiber Activation in Unipolar vs Bipolar Deep Brain Stimulation
-
TuneS: Patient-specific model-based optimization of contact configuration in deep brain stimulation